Clinical Trial Update: ALS Reversals - Lunasin Regimen [Phase 2]

View source ↗

Summary

Phase 2 trial update for a Lunasin regimen in ALS shows completed status with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Lunasin regimen (lunasin)

Snippet

Sponsor: Richard Bedlack, M.D., Ph.D. | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Status: COMPLETED | Results posted: 2018-12-13